Weight decrease neonatal and drugs of ingredients of allopurinol (a real world drug study)


Summary:

Weight decrease neonatal is reported only by a few people who take drugs with ingredients of allopurinol. This phase IV clinical study analyzes 193,129 people who have side effects while taking drugs with ingredients of allopurinol from the the FDA. Among them, 1 have Weight decrease neonatal. Find out below who they are, when they have Weight decrease neonatal and more.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Allopurinol, Lopurin, Zyloprim.


On Jun, 20, 2026

193,129 people reported to have side effects when taking drugs with ingredients of allopurinol.
Among them, 1 person (0.0%) has Weight decrease neonatal


What is Weight decrease neonatal?

Weight decrease neonatal is found to be associated with 25 drugs and 115 conditions by eHealthMe. Check the latest studies of Weight decrease neonatal.

Number of reports submitted per year:

Could drugs with ingredients of allopurinol cause Weight decrease neonatal?

Gender of people who have Weight decrease neonatal when taking drugs with ingredients of allopurinol *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Weight decrease neonatal when taking drugs with ingredients of allopurinol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
  2. Drug Dependence: 1 person, 100.00%
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 1 person, 100.00%
  4. Constipation: 1 person, 100.00%
  5. Alcoholism (problems with alcohol): 1 person, 100.00%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Subutex: 1 person, 100.00%
  2. Omeprazole: 1 person, 100.00%
  3. Nulytely: 1 person, 100.00%
  4. Augmentin '125': 1 person, 100.00%

Other side effects people have besides Weight decrease neonatal *:

You may use this to check any potential undetected side effects.

  1. Ventricular Fibrillation (abnormally irregular heart rhythm): 1 person, 100.00%
  2. Tremor Neonatal (excited neuromuscular activity of newborns): 1 person, 100.00%
  3. Hypertonia Neonatal (abnormal increase in muscle tension and a reduced ability of a muscle to stretch in neonatal): 1 person, 100.00%
  4. Growth Retardation (delayed growth): 1 person, 100.00%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
  6. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 1 person, 100.00%
  7. Foetal Alcohol Syndrome (a pattern of mental and physical defects that can develop in a foetus in association with high levels of alcohol consumption in pregnancy): 1 person, 100.00%
  8. Dysmorphism (difference of body structure that is suggestive of a congenital disorder): 1 person, 100.00%
  9. Drug Withdrawal Syndrome Neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother): 1 person, 100.00%
  10. Drowsiness: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of allopurinol, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: